GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis
2018 · Leukemia · 288 citations
https://doi.org/10.1038/s41375-018-0107-z
K
Kebede H. Begna
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
316
Papers
6.7K
Citations
37
h-index
114
i10-index
Kebede H. Begna is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment & Chronic Myeloid Leukemia Treatments. The author has an h-index of 37, co-authored 269 publications.
ORCID: 0000-0003-2730-8593Papers by this author
worksRefined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients
2010 · Leukemia · 175 citations
https://doi.org/10.1038/leu.2010.234
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
2024 · Journal of the National Comprehensive Cancer Network · 96 citations
https://doi.org/10.6004/jnccn.2024.0007
Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model
2019 · Blood Cancer Journal · 69 citations
https://doi.org/10.1038/s41408-019-0175-y
Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
2014 · Leukemia · 45 citations
https://doi.org/10.1038/leu.2014.306
Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
2020 · Blood Cancer Journal · 35 citations
https://doi.org/10.1038/s41408-020-00387-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat